Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Sowmya Kaur is the Executive Vice President and BU Head Clinical APAC/Russia at Navitas Life Sciences with a successful track record of building and leading Clinical Development engagements across Emerging Markets with successful delivery of portfolio of projects.
Articles by Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
4
Our Top 5 Most Read Articles in 2025
5